{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:09:33Z","timestamp":1773155373337,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12012-020-09595-1","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:36:26Z","timestamp":1598880986000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-4475","authenticated-orcid":false,"given":"Domas","family":"Vaitiekus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gintare","family":"Muckiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrone","family":"Vaitiekiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liveta","family":"Sereikaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Inciuraite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Insodaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiva","family":"Cepuliene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juozas","family":"Kupcinskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Ugenskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaldas","family":"Jurkevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elona","family":"Juozaityte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"9595_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"9595_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds293","author":"G Curigliano","year":"2012","unstructured":"Curigliano, G., Cardinale, D., Suter, T., et al. (2012). Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Annals of Oncology. https:\/\/doi.org\/10.1093\/annonc\/mds293.","journal-title":"Annals of Oncology"},{"key":"9595_CR3","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.190719","author":"K Rygiel","year":"2016","unstructured":"Rygiel, K. (2016). Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials. Indian Journal of Pharmacology. https:\/\/doi.org\/10.4103\/0253-7613.190719.","journal-title":"Indian Journal of Pharmacology"},{"issue":"7","key":"9595_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/cncr.32648","volume":"126","author":"AM Afifi","year":"2020","unstructured":"Afifi, A. M., Saad, A. M., Al-Husseini, M. J., Elmehrath, A. O., Northfelt, D. W., & Sonbol, M. B. (2020). Causes of death after breast cancer diagnosis: A US population-based analysis. Cancer, 126(7), 1559\u20131567. https:\/\/doi.org\/10.1002\/cncr.32648.","journal-title":"Cancer"},{"issue":"11","key":"9595_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jash.2014.08.009","volume":"8","author":"S Szmit","year":"2014","unstructured":"Szmit, S., Jurczak, W., Zaucha, J. M., Drozd-Soko\u0142owska, J., Spycha\u0142owicz, W., Joks, M., et al. (2014). Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma. Journal of the American Society of Hypertension, 8(11), 791\u2013799.","journal-title":"Journal of the American Society of Hypertension"},{"key":"9595_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9401","author":"L Gianni","year":"2008","unstructured":"Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B. (2008). Anthracycline cardiotoxicity: From bench to bedside. Journal of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.2007.14.9401.","journal-title":"Journal of Clinical Oncology"},{"key":"9595_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(01)97723-8","author":"F Arcamone","year":"1969","unstructured":"Arcamone, F., Franceschi, G., Penco, S., & Selva, A. (1969). Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Letters. https:\/\/doi.org\/10.1016\/S0040-4039(01)97723-8.","journal-title":"Tetrahedron Letters"},{"key":"9595_CR8","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.589834","author":"P Menna","year":"2012","unstructured":"Menna, P., Gonzalez Paz, O., Chello, M., Covino, E., Salvatorelli, E., & Minotti, G. (2012). Anthracycline cardiotoxicity. Expert Opinion on Drug Safety. https:\/\/doi.org\/10.1517\/14740338.2011.589834.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9595_CR9","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.59270","author":"M Valcovici","year":"2016","unstructured":"Valcovici, M., Andrica, F., Serban, C., & Dragan, S. (2016). Cardiotoxicity of anthracycline therapy: Current perspectives. https:\/\/doi.org\/10.5114\/aoms.2016.59270.Archives of Medical Science","journal-title":"Archives of Medical Science"},{"key":"9595_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1215","author":"A Seidman","year":"2002","unstructured":"Seidman, A., Hudis, C., Kathryn Pierri, M., et al. (2002). Cardiac dysfunction in the trastuzumab clinical trials experience. Journal of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.20.5.1215.","journal-title":"Journal of Clinical Oncology"},{"key":"9595_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-019-09556-3","author":"D Vaitiekus","year":"2019","unstructured":"Vaitiekus, D., Muckiene, G., Vaitiekiene, A., et al. (2019). Impact of arterial hypertension on doxorubicin-based chemotherapy-induced subclinical cardiac damage in breast cancer patients. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-019-09556-3.","journal-title":"Cardiovascular Toxicology"},{"issue":"8","key":"9595_CR12","first-page":"61","volume":"34","author":"RD Press","year":"1995","unstructured":"Press, R. D. (1995). Hemochromatosis: A \u201csimple\u201d genetic trait. Hospital Practice, 34(8), 61\u201368.","journal-title":"Hospital Practice"},{"key":"9595_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11607-2","author":"A Bomford","year":"2002","unstructured":"Bomford, A. (2002). Genetics of haemochromatosis. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(02)11607-2.","journal-title":"Lancet"},{"key":"9595_CR14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912233412607","author":"NC Andrews","year":"1999","unstructured":"Andrews, N. C. (1999). Disorders of iron metabolism. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJM199912233412607.","journal-title":"New England Journal of Medicine"},{"key":"9595_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.042701499","author":"A Waheed","year":"2002","unstructured":"Waheed, A., Grubb, J. H., Zhou, X. Y., et al. (2002). Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America. https:\/\/doi.org\/10.1073\/pnas.042701499.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9595_CR16","doi-asserted-by":"publisher","DOI":"10.1086\/524858","author":"E Beutler","year":"1997","unstructured":"Beutler, E. (1997). The significance of the 187G (H63D) mutation in hemochromatosis. American Journal of Human Genetics. https:\/\/doi.org\/10.1086\/524858.","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"9595_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejheart.2004.03.007","volume":"7","author":"J Hannuksela","year":"2005","unstructured":"Hannuksela, J., Leppilampi, M., Peuhkurinen, K., et al. (2005). Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. European Journal of Heart Failure, 7(1), 103\u2013108. https:\/\/doi.org\/10.1016\/j.ejheart.2004.03.007.","journal-title":"European Journal of Heart Failure"},{"key":"9595_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612123352403","author":"ZJ Bulaj","year":"1996","unstructured":"Bulaj, Z. J., Griffen, L. M., Jorde, L. B., Edwards, C. Q., & Kushner, J. P. (1996). Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJM199612123352403.","journal-title":"New England Journal of Medicine"},{"key":"9595_CR19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2000.00628.x","author":"B De Valk","year":"2000","unstructured":"De Valk, B., Addicks, M. A., Gosriwatana, I., Lu, S., Hider, R. C., & Marx, J. J. M. (2000). Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. European Journal of Clinical Investigation. https:\/\/doi.org\/10.1046\/j.1365-2362.2000.00628.x.","journal-title":"European Journal of Clinical Investigation"},{"key":"9595_CR20","doi-asserted-by":"publisher","DOI":"10.1042\/cs0680463","author":"JMC Gutteridge","year":"1985","unstructured":"Gutteridge, J. M. C., Rowley, D. A., Griffiths, E., & Halliwell, B. (1985). Low-molecular-weights iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clinical Science. https:\/\/doi.org\/10.1042\/cs0680463.","journal-title":"Clinical Science"},{"key":"9595_CR21","first-page":"23","volume":"23","author":"RT Dorr","year":"1996","unstructured":"Dorr, R. T. (1996). Cytoprotective agents for anthracyclines. Seminars in Oncology, 23, 23\u201334.","journal-title":"Seminars in Oncology"},{"key":"9595_CR22","doi-asserted-by":"publisher","DOI":"10.5555\/uri:pii:002221439390070F","author":"C Hershko","year":"1993","unstructured":"Hershko, C., Link, G., Tzahor, M., et al. (1993). Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: Studies in rat heart cells in culture. Journal of Laboratory and Clinical Medicine. https:\/\/doi.org\/10.5555\/uri:pii:002221439390070F.","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"9595_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(96)90095-5","author":"G Link","year":"1996","unstructured":"Link, G., Tirosh, R., Pinson, A., & Hershko, C. (1996). Role of iron in the potentiation of anthracycline cardiotoxicity; identification of heart cell mitochondria as a major site of iron-anthracycline interaction. Journal of Laboratory and Clinical Medicine. https:\/\/doi.org\/10.1016\/S0022-2143(96)90095-5.","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"9595_CR24","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.4.888","author":"JC Kwok","year":"2002","unstructured":"Kwok, J. C., & Richardson, D. R. (2002). Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: The iron and copper complexes of anthracyclines decrease RNA-binding activity. Molecular Pharmacology. https:\/\/doi.org\/10.1124\/mol.62.4.888.","journal-title":"Molecular Pharmacology"},{"key":"9595_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(80)90189-9","author":"PM May","year":"1980","unstructured":"May, P. M., Williams, G. K., & Williams, D. R. (1980). Solution chemistry studies of adriamycin-iron complexes present in vivo. European Journal of Cancer and Clinical Oncology. https:\/\/doi.org\/10.1016\/0014-2964(80)90189-9.","journal-title":"European Journal of Cancer and Clinical Oncology"},{"issue":"7","key":"9595_CR26","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1182\/blood-2003-03-0869","volume":"102","author":"CJ Miranda","year":"2003","unstructured":"Miranda, C. J., Makui, H., Soares, R. J., et al. (2003). Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood, 102(7), 2574\u20132580. https:\/\/doi.org\/10.1182\/blood-2003-03-0869.","journal-title":"Blood"},{"issue":"19","key":"9595_CR27","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/cncr.28256.Impact","volume":"119","author":"SE Lipshultz","year":"2014","unstructured":"Lipshultz, S. E., Lipsitz, S. R., Kutok, J. L., et al. (2014). Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer, 119(19), 3555\u20133562. https:\/\/doi.org\/10.1002\/cncr.28256.Impact.","journal-title":"Cancer"},{"issue":"3","key":"9595_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S., Neale, B., Todd-Brown, K., et al. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81(3), 559\u2013575. https:\/\/doi.org\/10.1086\/519795.","journal-title":"American Journal of Human Genetics"},{"key":"9595_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-014-0315-4","author":"S Raj","year":"2014","unstructured":"Raj, S., Franco, V. I., & Lipshultz, S. E. (2014). Anthracycline-induced cardiotoxicity: A review of pathophysiology, diagnosis, and treatment. Current Treatment Options in Cardiovascular Medicine. https:\/\/doi.org\/10.1007\/s11936-014-0315-4.","journal-title":"Current Treatment Options in Cardiovascular Medicine"},{"key":"9595_CR30","doi-asserted-by":"publisher","DOI":"10.5301\/jbm.5000041","author":"D Vivenza","year":"2013","unstructured":"Vivenza, D., Feola, M., Garrone, O., Monteverde, M., Merlano, M., & Lo, N. C. (2013). Role of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma. International Journal of Biological Markers. https:\/\/doi.org\/10.5301\/jbm.5000041.","journal-title":"International Journal of Biological Markers"},{"key":"9595_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq159","author":"S Aebi","year":"2010","unstructured":"Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010). Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. https:\/\/doi.org\/10.1093\/annonc\/mdq159.","journal-title":"Annals of Oncology"},{"key":"9595_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","volume":"61","author":"T \u0160im\u016fnek","year":"2009","unstructured":"\u0160im\u016fnek, T., \u0160t\u011brba, M., Popelov\u00e1, O., Adamcov\u00e1, M., Hrdina, R., & Ger\u0161i, V. (2009). Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacological Reports, 61, 154\u2013171. https:\/\/doi.org\/10.1016\/S1734-1140(09)70018-0.","journal-title":"Pharmacological Reports"},{"issue":"2","key":"9595_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa, Y., Ghanefar, M., Bayeva, M., et al. (2014). Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation, 124(2), 617\u2013630. https:\/\/doi.org\/10.1172\/JCI72931.","journal-title":"Journal of Clinical Investigation"},{"key":"9595_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11407","author":"SM Swain","year":"2003","unstructured":"Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003). Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer. https:\/\/doi.org\/10.1002\/cncr.11407.","journal-title":"Cancer"},{"key":"9595_CR35","first-page":"525","volume":"25","author":"J Speyer","year":"1998","unstructured":"Speyer, J., & Wasserheit, C. (1998). Strategies for reduction of anthracycline cardiac toxicity. Seminars in Oncology, 25, 525\u2013537.","journal-title":"Seminars in Oncology"},{"issue":"3","key":"9595_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2125.1991.tb05525.x","volume":"31","author":"N Campbell","year":"1991","unstructured":"Campbell, N., & Hasinoff, B. (1991). Iron supplements: A common cause of drug interactions. British Journal of Clinical Pharmacology, 31(3), 251\u2013255. https:\/\/doi.org\/10.1111\/j.1365-2125.1991.tb05525.x.","journal-title":"British Journal of Clinical Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-020-09595-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:36:50Z","timestamp":1627947410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-020-09595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["9595"],"URL":"https:\/\/doi.org\/10.1007\/s12012-020-09595-1","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Permission from the Kaunas regional Bioethics Committee was obtained. (Nos.: BEC MF 361; BE-2-10 and P1-BE-2-10\/2014).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients gave written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}